# A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

> **NCT04072497** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 522 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** One shot of the zoster vaccine
- **BIOLOGICAL:** One shot of the varicella vaccine
- **BIOLOGICAL:** one shot of placebo

## Key facts

- **NCT ID:** NCT04072497
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-20
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 522 (ACTUAL)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072497, "A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04072497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*